< Back to companies
Bell Therapeutics (벨테라퓨틱스)

Bell Therapeutics (벨테라퓨틱스)

Daejeon, South Korea

Bell Therapeutics is a digital therapeutics (DTx) startup that treats diseases using real-time digital sound technology. BELL is developing next-generation digital therapeutics that implement the drug mechanism in software. It provides optimized solutions for patients by utilizing digital infrastructure such as smartphone sensors and cloud computing, and its mechanism of action is based on neuroscience mechanisms. The BELL team consists of experts in brain science, auditory neuroscience, music therapy, and music signal processing, and is preparing to enter the global medical market after successfully completing the efficacy clinical trial conducted at Seoul National University Hospital.

Share
Shareable draft
Get Involved in Bell Therapeutics (벨테라퓨틱스)

Company Info

Founded
2023
Website
www.belltherapeutics.com/

Categories

Digital TherapeuticsTherapeuticsNeurologyDigital Health Services

Disease Areas

Technologies

Digital TherapeuticsCloud ComputingSensorsNeuroscience
Only accessible to MedStartr community members. Join now

What do you think of Bell Therapeutics (벨테라퓨틱스)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Bell Therapeutics (벨테라퓨틱스)
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free